BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8938108)

  • 1. Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: role of decreased intracellular TNF-alpha.
    Kovacs B; Vassilopoulos D; Vogelgesang SA; Tsokos GC
    Clin Immunol Immunopathol; 1996 Dec; 81(3):293-302. PubMed ID: 8938108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus.
    Kovacs B; Liossis SN; Dennis GJ; Tsokos GC
    Autoimmunity; 1997; 25(4):213-21. PubMed ID: 9344329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7/BB1 provides an important costimulatory signal for CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus (SLE).
    Sfikakis PP; Oglesby R; Sfikakis P; Tsokos GC
    Clin Exp Immunol; 1994 Apr; 96(1):8-14. PubMed ID: 7512010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus.
    Vassilopoulos D; Kovacs B; Tsokos GC
    J Immunol; 1995 Aug; 155(4):2269-81. PubMed ID: 7636273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE).
    Bijl M; Horst G; Limburg PC; Kallenberg CG
    Clin Exp Immunol; 2001 Jan; 123(1):127-32. PubMed ID: 11168009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM; Taher TE; Isenberg DA; Mageed RA
    Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus.
    Gergely P; Grossman C; Niland B; Puskas F; Neupane H; Allam F; Banki K; Phillips PE; Perl A
    Arthritis Rheum; 2002 Jan; 46(1):175-90. PubMed ID: 11817589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
    Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
    Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis.
    Kaneko H; Saito K; Hashimoto H; Yagita H; Okumura K; Azuma M
    Clin Exp Immunol; 1996 Nov; 106(2):218-29. PubMed ID: 8918566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
    Suzuki N; Ichino M; Mihara S; Kaneko S; Sakane T
    Arthritis Rheum; 1998 Feb; 41(2):344-53. PubMed ID: 9485093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent expression of a soluble form of Fas/APO1 in continuously activated T cells from a patient with SLE.
    Kovacs B; Szentendrei T; Bednarek JM; Pierson MC; Mountz JD; Vogelgesang SA; Tsokos GC
    Clin Exp Rheumatol; 1997; 15(1):19-23. PubMed ID: 9093768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
    J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced phosphoinositide 3-kinase δ activity is a frequent event in systemic lupus erythematosus that confers resistance to activation-induced T cell death.
    Suárez-Fueyo A; Barber DF; Martínez-Ara J; Zea-Mendoza AC; Carrera AC
    J Immunol; 2011 Sep; 187(5):2376-85. PubMed ID: 21810603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.
    Yang W; Hussain S; Mi QS; Santamaria P; Delovitch TL
    J Immunol; 2004 Oct; 173(7):4407-16. PubMed ID: 15383571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on corelation between InsP(3) generation and TCR/ CD3 complex-mediated [Ca(2+)]i responses in T cells from SLE patients].
    Yang QY; Liao YX; Wang ZF; Yang HL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Mar; 19(2):142-4. PubMed ID: 15151751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand.
    Georgescu L; Vakkalanka RK; Elkon KB; Crow MK
    J Clin Invest; 1997 Nov; 100(10):2622-33. PubMed ID: 9366578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-induced death of T-lymphocytes.
    Kabelitz D; Janssen O
    Front Biosci; 1997 Feb; 2():d61-77. PubMed ID: 9159213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas (CD95)-transduced signal preferentially stimulates lupus peripheral T lymphocytes.
    Sakata K; Sakata A; Vela-Roch N; Espinosa R; Escalante A; Kong L; Nakabayashi T; Cheng J; Talal N; Dang H
    Eur J Immunol; 1998 Sep; 28(9):2648-60. PubMed ID: 9754553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells.
    Kaplan MJ; Lewis EE; Shelden EA; Somers E; Pavlic R; McCune WJ; Richardson BC
    J Immunol; 2002 Nov; 169(10):6020-9. PubMed ID: 12421989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.